Skip to content

A non-randomized confirmatory trial of Cold Snare Polypectomy for Superficial Non-Ampullary Duodenal Epithelial Tumor (D-COP trial)

A non-randomized confirmatory trial of Cold Snare Polypectomy for Superficial Non-Ampullary Duodenal Epithelial Tumor (D-COP trial) - A non-randomized confirmatory trial of Cold Snare Polypectomy for Superficial Non-Ampullary Duodenal Epithelial Tumor (D-COP trial)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030876
Enrollment
330
Registered
2018-01-18
Start date
2018-01-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial non-ampullary deuodenal epithelial tumor (SNADET)

Interventions

DCSP

Sponsors

Shizuoka Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) superficial non-ampullary duodenal epithelial tumor <= 10mm 2) bulbs ~ 3rd part of deudenum 3) 3 lesions or less 4) lesion expected to remove en-block using snare 5) 20 years old and more 6) can be followed for 12 months 7) Written informed consent

Exclusion criteria

Exclusion criteria: 1) FAP patients 2) Impossible to suspend anticoagulant or antiplatelet medications (except low-dose aspirin) 3) Infectious disease with systemic therapy indicated 4) Psychosis 5) Systemic steroids medication 6) History of myocardial infarction within 6 months or unstable angina pectoris within 3 weeks 7) Severe respiratory disease requiring continuous oxygen therapy 8) Uncontrollable hypertension 9) others

Design outcomes

Primary

MeasureTime frame
the rate of local recurrence in 12 months

Secondary

MeasureTime frame
Delayed perforation and bleeding

Countries

Japan

Contacts

Public ContactKOHEI TAKIZAWA

Shizuoka Cancer Center Division of Endoscopy

k.takizawa@scchr.jp055-989-5222(ext.2270)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026